Embargo Watch

Keeping an eye on how scientific information embargoes affect news coverage

Posts Tagged ‘embargo breaks

PNAS lifts fructose-appetite study embargo early after realizing media had covered presentation months ago

leave a comment »

pnas junePNAS sent a message to its media list on Friday that began:

PNAS is lifting the embargo early on the following paper. All other articles are under the scheduled embargo:

Glucose, fructose, and appetite

Fructose may enhance the reward value of high-calorie food and promote eating, compared with glucose, according to a study. Differences in metabolism of fructose and glucose may lead to differential effects on physiological and behavioral responses to food. To assess the different effects of the two sugars on hunger and food cue responses in the brain, Kathleen A. Page and colleagues conducted fMRI scans on 24 people who had been given drinks sweetened with fructose on one day and glucose on another day.

The journal tells Embargo Watch: Read the rest of this entry »

Written by Ivan Oransky

May 4, 2015 at 10:00 am

Posted in Uncategorized

Tagged with ,

Menopause study embargo lifted early after Sunday Times story, but Jonathan Leake notes abstracts were freely available

with 6 comments

Ah, vacation. That protected time when you don’t check your email or voicemail, and you don’t blog. Well, I kept to that last bit, anyway, while traipsing around Turkey and trying unsuccessfully to avoid Turkish Viagra.

But embargo news doesn’t stop in its tracks just because Embargo Watch is on vacation. In the next few days, I’ll use posts to catch up on that news.

First up: On Sunday, European Society of Human Reproduction and Embryology (ESHRE) press officer Emma Mason sent out the following message: Read the rest of this entry »

Written by Ivan Oransky

June 30, 2010 at 9:15 am

*Assisted fertility-birth abnormalities embargo lifted early after Sunday Times story but “it appears that they are not entirely to blame this time”

with one comment

The Sunday Times has broken another embargo, this one of a study on a higher risk of birth abnormalities among babies conceived through assisted fertility treatments. The study is scheduled to be presented tomorrow (Monday) at the European Society of Human Genetics meeting in Gothenburg, Sweden, and was embargoed until a minute after midnight Central European Time Monday. The Sunday Times story, by Jonathan Leake, was posted sometime late Saturday.

However, according to from Mary Rice, who is handling media relations on the study, there’s more to the embargo break. In an email sent to her press list at 5:34 a.m. Eastern today, she wrote: Read the rest of this entry »

Written by Ivan Oransky

June 13, 2010 at 9:05 am

Posted in Uncategorized

Tagged with

CNN breaks embargo on stress and breast cancer study in Clinical Cancer Research

with 2 comments

The embargo should be lifting in two minutes, at 1 p.m. Eastern, on a study in Clinical Cancer Research which found that lowering stress among women with breast cancer was linked to better outcomes. But an item about the study went live on CNN’s Paging Dr. Gupta blog at 10 a.m. Eastern.

Jeff Grabmeier, director of research communications at Ohio State University, where the study’s lead researcher works, emailed me about the break a bit before noon. He said a local reporter had come across the CNN item. Jeff called the American Association for Cancer Research (AACR), the journal’s publisher, and a press officer there told him that they’d contact CNN to see if they could take down the item. Read the rest of this entry »

Written by Ivan Oransky

June 8, 2010 at 12:57 pm

Another government agency upholds embargo, on supplement safety report, despite a New York Times exclusive

leave a comment »

Remember the President’s Cancer Panel report on environmental causes of cancer, the one a PR agency gave The New York Times‘ Nick Kristof to run with while holding every other reporter to an embargo?

Well, a similar thing happened this morning: New York Times reporter Gardiner Harris had an exclusive on a Government Accountability Office (GAO) report on the safety of herbal supplements, but the Senate committee where that report is being delivered this afternoon told everyone else it was still embargoed until 2 p.m. Eastern, as originally planned. From Gardiner’s story: Read the rest of this entry »

Written by Ivan Oransky

May 26, 2010 at 2:05 pm

Posted in Uncategorized

Tagged with

Science Venter study on “synthetic cell” embargo broken

with one comment

When it rains, it pours, at least when it comes to embargo breaks, apparently. While I was conducting this interview with Daniel Carlat between noon and one today, two notices about early embargo lifts went out. One was about this ASCO Rituxan break, and here’s the other:

The AAAS Office of Public Programs is lifting the embargo, effective immediately, on the Science article “Creation of a Bacterial Cell Controlled by a Chemically Synthesized Genome,” by D. Gibson and colleagues, because this information has entered the public domain.

A summary of the article follows, and a copy of the manuscript is available at http://www.eurekalert.org/jrnls/sci/. The embargo is being lifted so that reporters may freely publish their coverage now. The rest of this week’s SciPak content will remain under embargo until 2 pm US ET today, 20 May.

I should note that at 1:30 p.m. Eastern, when I went to the Science site, all of the material from the May 21 issue seemed to be live. Read the rest of this entry »

Written by Ivan Oransky

May 20, 2010 at 1:34 pm

ASCO rituximab (Rituxan) lymphoma embargo broken

leave a comment »

It’s ASCO time, with the embargo on most conference abstracts lifting tonight at 6 p.m. Eastern, and the media circus has already tossed off one embargo break, according to an email sent out at 12:20 Eastern:

Due to an embargo break, the American Society of Clinical Oncology (ASCO) has lifted the embargo on the abstract titled, “Rituximab maintenance for 2 years in patients with untreated high tumor burden follicular lymphoma after response to immunochemotherapy.”

Reporters are free to publish stories on this study, which was supposed to be embargoed until 6:00 PM (EDT) today. A media summary of the study is copied below, along with the abstract.  ASCO is investigating the reasons for this embargo break.

I’ve learned that a release about the study went out early this morning on PR Newswire. Read the rest of this entry »

Written by Ivan Oransky

May 20, 2010 at 1:20 pm

Posted in Uncategorized

Tagged with ,

Follow

Get every new post delivered to your Inbox.

Join 25,498 other followers